Fluids and Barriers of the CNS · 2024 · 25 citations · 332 references
Life SciencesGeneticsMolecular GeneticsMedical GeneticsNeurogeneticsPathophysiologyEndoscopic Third VentriculostomyIntracranial HypertensionIntracranial PressureEndoscopic VentriculostomyHydrocephalus PathogenesisHydrocephalus PathophysiologyIncreased Intracranial PressureIntracranial Pressure DynamicsIntraventricular Hemorrhage-associated HydrocephalusMolecular Genetic ArchitectureSurgical Shunting
Hydrocephalus (HC) is a heterogenous disease characterized by alterations in cerebrospinal fluid (CSF) dynamics that may cause increased intracranial pressure. HC is a component of a wide array of genetic syndromes as well as a secondary consequence of brain injury (intraventricular hemorrhage (IVH), infection, etc.) that can present across the age spectrum, highlighting the phenotypic heterogeneity of the disease. Surgical treatments include ventricular shunting and endoscopic third ventriculostomy with or without choroid plexus cauterization, both of which are prone to failure, and no effective pharmacologic treatments for HC have been developed. Thus, there is an urgent need to understand the genetic architecture and molecular pathogenesis of HC. Without this knowledge, the development of preventive, diagnostic, and therapeutic measures is impeded. However, the genetics of HC is extraordinarily complex, based on studies of varying size, scope, and rigor. This review serves to provide a comprehensive overview of genes, pathways, mechanisms, and global impact of genetics contributing to all etiologies of HC in humans.
332
The PRISMA 2020 statement: an updated guideline for reporting systematic reviews
Matthew J. Page, Joanne E. McKenzie, Patrick M. Bossuyt et al. · BMJ · 2021 · 95K citations · Full text
Mutations in SUFU predispose to medulloblastoma
Michael D. Taylor, Ling Liu, Corey Raffel et al. · Nature Genetics · 2002 · 799 citations